New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of Screening

Clin Gastroenterol Hepatol. 2022 Sep;20(9):1927-1930. doi: 10.1016/j.cgh.2022.02.015. Epub 2022 Feb 15.

Authors

Natalia Khalaf¹, Basim Ali²

Affiliations

¹ Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: natalia.khalaf@bcm.edu.
² Department of Medicine, Baylor College of Medicine, Houston, Texas.

PMID: 35181568
DOI: 10.1016/j.cgh.2022.02.015

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Diabetes Mellitus*
Diabetes Mellitus, Type 2*
Early Detection of Cancer
Humans
Mass Screening
Pancreatic Neoplasms*
Risk Factors

Grants and funding

IK2 HX003346/HX/HSRD VA/United States